VectivBio Announces Results of Extraordinary General Meeting
BASEL, Switzerland, Dec. 09, 2022 (GLOBE NEWSWIRE) -- VectivBio Holding AG ("VectivBio") (NASDAQ:VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare
Owning 46% Shares,institutional Owners Seem Interested in Forbion European Acquisition Corp. (NASDAQ:FRBN),
Short Interest in Forbion European Acquisition Corp. (NASDAQ:FRBN) Rises By 16.7%
Forbion European Acquisition Corp. (NASDAQ:FRBN – Get Rating) was the recipient of a significant growth in short interest in September. As of September 30th, there was short interest totalling 700 sh
Short Interest in Forbion European Acquisition Corp. (NASDAQ:FRBN) Grows By 100.0%
Forbion European Acquisition Corp. (NASDAQ:FRBN – Get Rating) was the target of a significant increase in short interest during the month of August. As of August 31st, there was short interest totall
NASDAQ TRADE HALT FRBN.O VOLATILITY TRADING PAUSE AT 10:09 AM
NASDAQ TRADE HALT FRBN.O VOLATILITY TRADING PAUSE AT 10:09 AM
Loading...
No Stock Yet